Please use this identifier to cite or link to this item:
|Title:||Cardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 Trial|
Forbes, John F.
School of Public Health: Public Health
|Publisher:||American Society of Clinical Oncology|
|Citation:||Cardiovascular Adverse Events During Adjuvant Endocrine Therapy for Early Breast Cancer Using Letrozole or Tamoxifen: Safety Analysis of BIG 1-98 Trial, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.25,(36),2007,pp 5715-5722|
|Department/Unit/Centre:||School of Public Health: Public Health|
|Disclaimer:||This work has been made available to the staff and students of the University of Sydney for the purposes of research and study only. It constitutes material that is held by the University for the purposes of reporting for HERDC and the ERA. This work may not be downloaded, copied and distributed to any third party .|
|Type:||C1 - Refereed Journal articles|
|Appears in Collections:||University of Sydney Research Outputs|
Items in Sydney Research Online are protected by copyright, with all rights reserved, unless otherwise indicated.